Treatment Considerations for Patients Researching Their Options
During this segment, Dr. Michael Pishvaian explains why patients with pancreatic cancer need to be proactive in researching available treatment options (including those in clinical trials) and meeting with multiple physicians to discuss their options. He explains the future of molecular profiling in the disease and suggests that patients seek reputable information from advocacy groups such as the Pancreatic Cancer Action Network. In an attempt to educate patients about a promising therapy option, NanoKnife treatment, David Shell highlights a Facebook page he developed.
PUBLISHED January 20, 2016